Provectus Pharmaceuticals, Inc.

KNOXVILLE, Tenn., March 30 /PRNewswire-FirstCall/ -- Provectus Pharmaceuticals, Inc. (OTC Bulletin Board: PVCT - News), an innovative biopharmaceutical company engaged in the research and development of breakthrough technologies for metastatic melanoma, psoriasis, breast cancer and other serious diseases, announced today that significant operational and financial progress was made in the year ended December 31, 2005. Financial results for 2005 can be found in the Form 10KSB filed with the U.S. Securities and Exchange Commission (SEC) on March 30, 2006, which is accessible at the SEC website at http://www.sec.gov .

Comment - PUT THIS COMPANY ON YOUR MAP AND WATCH It !!!!